Engineered Bio-Based Hydrogels for Cancer Immunotherapy

© 2024 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 21 vom: 31. Mai, Seite e2313188
1. Verfasser: Peng, Yuxuan (VerfasserIn)
Weitere Verfasser: Liang, Shuang, Meng, Qian-Fang, Liu, Dan, Ma, Kongshuo, Zhou, Mengli, Yun, Kaiqing, Rao, Lang, Wang, Zhaohui
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Review bio‐based hydrogels cancer treatment immune activation immunotherapy localized administration Hydrogels Biocompatible Materials
Beschreibung
Zusammenfassung:© 2024 Wiley‐VCH GmbH.
Immunotherapy represents a revolutionary paradigm in cancer management, showcasing its potential to impede tumor metastasis and recurrence. Nonetheless, challenges including limited therapeutic efficacy and severe immune-related side effects are frequently encountered, especially in solid tumors. Hydrogels, a class of versatile materials featuring well-hydrated structures widely used in biomedicine, offer a promising platform for encapsulating and releasing small molecule drugs, biomacromolecules, and cells in a controlled manner. Immunomodulatory hydrogels present a unique capability for augmenting immune activation and mitigating systemic toxicity through encapsulation of multiple components and localized administration. Notably, hydrogels based on biopolymers have gained significant interest owing to their biocompatibility, environmental friendliness, and ease of production. This review delves into the recent advances in bio-based hydrogels in cancer immunotherapy and synergistic combinatorial approaches, highlighting their diverse applications. It is anticipated that this review will guide the rational design of hydrogels in the field of cancer immunotherapy, fostering clinical translation and ultimately benefiting patients
Beschreibung:Date Completed 24.05.2024
Date Revised 24.05.2024
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202313188